Advertisement
Journal Home
Search for

Volume 38, Issue 1, Pages 46-56 (January 2010)


View previous. 7 of 8 View next.

Altered “set-point” of the hypothalamus determines effects of cortisol on food intake, adiposity, and metabolic substrates in sheep

B.A. HenryaCorresponding Author Informationemail address, D. Blacheb, F.R. Dunsheac, I.J. Clarkea

Received 14 May 2009; received in revised form 1 July 2009; accepted 14 July 2009. published online 04 September 2009.

Abstract 

Chronic elevation of glucocorticoid concentrations is detrimental to health. We investigated effects of chronic increase in plasma cortisol concentrations on energy balance and endocrine function in sheep. Because food intake and reproduction are regulated by photoperiod, we performed experiments in January (JAN) and August (AUG), when appetite drive is either high or low, respectively. Ovariectomized ewes were treated (intramuscularly) daily with 0.5mg Synacthen Depot® (synthetic adrenocorticotropin: ACTH) or saline for 4 wk. Blood samples were taken to measure plasma concentrations of cortisol, luteinising hormone (LH), follicle-stimulating hormone (FSH), growth hormone (GH), leptin, insulin, and glucose. Adrenocorticotropin treatment increased concentrations of cortisol. During JAN, treatment reduced food intake transiently, but increased food intake in AUG. Leptin concentrations were reduced and glucose concentrations were greater in AUG, and insulin concentrations were similar throughout the year. Treatment with ACTH increased leptin concentrations in AUG only, whereas insulin concentrations increased in JAN only. Synacthen treatment increased glucose concentrations, with a greater effect in JAN. Changes in truncal adiposity and ACTH-induced cortisol secretion were positively correlated in JAN and negatively correlated in AUG. Treatment reduced the plasma LH pulse frequency in JAN and AUG, with an effect on pulse amplitude in JAN only. Treatment did not affect plasma GH or FSH concentrations. We conclude that chronically elevated cortisol concentrations can affect food intake, adiposity, and reproductive function. In sheep, effects of chronically elevated cortisol concentrations on energy balance and metabolism depend upon metabolic setpoint, determined by circannual rhythms.

Article Outline

Abstract

1. Introduction

2. Materials and Methods

2.1. Animals

2.2. Blood sampling and endocrine measurements

2.2.1. Blood sampling

2.2.2. Cortisol

2.2.3. Growth hormone

2.2.4. Luteinizing hormone

2.2.5. Follicle-stimulating hormone

2.2.6. Leptin

2.2.7. Insulin

2.2.8. Pulse and endocrine analyses

2.3. Metabolic and morphometric analyses

2.3.1. Plasma glucose concentrations

2.3.2. Food intake, body weight, and adiposity

2.4. Statistical analysis

3. Results

3.1. Effect of ACTH treatment on plasma cortisol concentrations

3.2. Effect of chronic elevation in cortisol concentrations on food intake, body weight, omental fat, and truncal adiposity

3.3. Effect of chronic elevation in cortisol concentration on plasma concentrations of leptin, insulin and glucose

3.4. Effect of chronic elevation in cortisol secretion on the secretory profiles of GH and gonadotropins

4. Discussion

Acknowledgment

References

Copyright

1. Introduction 

return to Article Outline

Activation of the hypothalamo-pituitary-adrenal (HPA) axis is a hallmark response to stress, which culminates in increased secretion of glucocorticoids from the adrenal gland. In humans and sheep, the predominant glucocorticoid secreted is cortisol. In various animal models and in humans, prolonged activation of the HPA axis, or chronically increased concentrations of glucocorticoids, is detrimental to a variety of physiological systems. Persistent and uncontrolled secretion of glucocorticoids results in the development of affective disorders, impairs fertility, and influences energy homeostasis [1], [2]

In humans, chronic elevation in cortisol concentrations has been associated with the development of obesity. A classic example is Cushing's disease, which is characterized by enhanced secretion of cortisol and increased adiposity, particularly truncal or central adiposity [3]. In addition, in non-Cushingoid patients, the degree of cortisol responsiveness following stress influences the metabolic response such that subjects classified as “high-cortisol responders” exhibit increased caloric consumption after a stressful episode compared to subjects classified as “low-cortisol responders” [4]. In contrast, others [5] have found that increasing levels of stress reduce food intake in a subgroup (around 30%) of human patients. Hitherto, defining the effects of stress and increased concentrations of cortisol on feeding behavior and body weight has proven difficult owing to the dichotomous findings.

It has proven difficult to develop an animal model to study glucocorticoid-induced feeding. In some cases, such as genetic forms of obesity including the ob/ob mouse and the fatty Zucker rat, animals display both profound obesity and elevated concentrations of corticosterone [6], [7]. Adrenalectomy attenuates or may even reverse the obese phenotype in these models [6], [7]. In sheep, hypothalamo-pituitary disconnection (HPD), results in a number of neuroendocrine perturbations including elevated basal (non-stressed) circulating concentrations of cortisol [8], and these animals gain adiposity [9]. These animals, however, have other complications such as loss of growth hormone and thyroid stimulating hormone secretion and loss of the arcuate nucleus resulting from the operative procedure. In spite of the aforementioned cases, it still remains controversial as to whether increased glucocorticoid concentrations in normal animals can trigger weight gain through increased adiposity.

In humans, prednisolone treatment increases food intake within 7 d [10], whereas dexamethasone reduces food intake in rodents [11]. Repeated-restraint stress (5 d) also reduces total daily food intake and body weight in rats, despite the animals exhibiting preference for palatable lard and sugar diets [12]. A central objective of the current study was to establish a model of glucocorticoid-induced feeding and weight gain in a different species. We investigated the effects of chronic elevation in plasma cortisol (4 wk) on metabolic output and the endocrine systems controlling metabolism and reproduction in sheep, and we replicated the study at 2 times of the year, when inherent appetite drive is either high or low [13], [14].

2. Materials and Methods 

return to Article Outline

2.1. Animals 

This work was approved in advance by the animal ethics committees of the Victorian Department of Primary Industries and Monash University. Corriedale ewes (n=5 or 6/group) were ovariectomized at least 1 mo prior to experimentation. Experiments were carried out under natural photoperiod at the Monash University Large Animal Facility, Werribee, Victoria. During the experiments, the animals were kept indoors in individual pens (1.3×0.9 m) and were exposed to natural variations in temperature and humidity. Ewes were selected for study in January (JAN: southern hemisphere breeding season and when voluntary food intake is highest, n=5/group) and again in August (AUG: nonbreeding season and the time when voluntary food intake is at a nadir, n=6/group) [14]. Sustained elevation of plasma concentrations of cortisol was achieved by daily (9:00 AM) intramuscular (i.m.) injection of Synacthen Depot (0.5mg) for 4 wk, and control animals received an equal volume of sterile saline (0.5mL). This dose was based on previous reports that 0.5mg of Synacthen Depot administered i.m. produced a sustained rise in plasma cortisol concentration in sheep [15].

2.2. Blood sampling and endocrine measurements 

2.2.1. Blood sampling 

Serial blood samples (6mL) were taken prior to the initiation of treatment and again at the end of the 4-wk treatment regime. To facilitate the sampling, an indwelling cannula was inserted into one external jugular vein, extended with a manometer line (Portex Ltd., Kent, UK), and closed with a 3-way tap on the day prior to sampling. Samples were taken at 10-min intervals for 8h (9:00 AM-5:00 PM) into heparinized tubes, the blood was centrifuged, and the plasma was harvested. Plasma was stored at -20°C for radioimmunoassay to measure cortisol, luteinizing hormone (LH), follicle-stimulating hormone (FSH), growth hormone (GH), and leptin.

2.2.2. Cortisol 

Samples (100μL) were assayed in duplicate in accordance with the method of Bocking et al. [16]. For 20 assays, the interassay coefficient of variation (CV) was 9.8%, the intra-assay CV was 8.0%, and the sensitivity of the assay was 0.4ng/mL.

2.2.3. Growth hormone 

For the GH assay, samples (200μL) were assayed in duplicate following the method of Thomas et al. [17] using the standard NIDDK-oGH-I-4. For 10 assays, the interassay CV was 8.7%, the intra-assay CV was<10% between 8.2- 17.1ng/mL, and the sensitivity was 1.4ng/mL.

2.2.4. Luteinizing hormone 

Samples (100μL) were assayed in duplicate following the method of Lee et al. [18] using the ovine standard NIH oLH-S18. Samples were measured across 18 assays; the interassay CV was 9.2%, the intra-assay CV was<10% between 0.5- 11.3ng/mL, and the sensitivity was 0.2ng/mL.

2.2.5. Follicle-stimulating hormone 

To measure FSH, hourly samples were selected across the 8-h sampling period using the ovine standard NIAMMD oFSH-RP-1. Samples (100μL) were assayed in duplicate using the method of Bremner et al. [19]. For 2 assays, the interassay CV was 7.4%, the intra-assay CV was<10% between 0.7- 68.2ng/mL, and the sensitivity of the assay was 0.1 ng/mL.

2.2.6. Leptin 

For measurement of plasma leptin concentrations, blood samples were taken at 9:00 AM prior to treatment and at the end of the 4-wk treatment period. Plasma leptin concentrations were determined using the radioimmunoassay described by Blache et al. [20]. Samples (100μL) were assayed in duplicate, the assay sensitivity was 0.05ng/mL, and the intra-assay CV was 4.3% at 0.46ng/mL, 4.9% at 0.9ng/mL, and 6.5 % at 2.1ng/mL.

2.2.7. Insulin 

For the measurement of plasma metabolites, blood samples (10mL) were taken by venipuncture each wk prior to feeding (9:00 AM). These samples were used to measure plasma concentrations of glucose (see below) and insulin. Plasma insulin concentrations were measured using a radioimmunoassay kit (Linco, St. Charles, MO, USA) validated for the measurement of ovine insulin [21]. All samples were measured in a single assay for which the intra-assay coefficient of variation was<10% between 24.6–37.7μU/mL and the assay sensitivity was 2.4μU/mL.

2.2.8. Pulse and endocrine analyses 

The mean plasma concentration was used to assess effects of chronic elevation in cortisol on plasma concentrations of FSH and leptin. The secretory profiles of LH and GH were characterized using pulse analysis techniques. For LH, standard pulse analysis techniques were performed [22]. The mean GH concentration, GH pulse amplitude, and GH interpulse interval were characterized using the pulse analysis program TURBOPULSAR [23], using previously defined G-parameters [21].

2.3. Metabolic and morphometric analyses 

2.3.1. Plasma glucose concentrations 

Plasma concentrations of glucose were measured in 25-μL samples of plasma using a YSI2300 STAT glucose/lactate analyzer (Yellow Springs Instrument Co., Yellow Springs, OH).

2.3.2. Food intake, body weight, and adiposity 

Animals were fed 2kg of lucerne chaff daily at 9:00 AM; food intake was calculated by weighing refusal. Food intake was determined for 1 wk prior to the commencement and for the duration of the experiment. Animals were weighed weekly, and truncal and visceral adiposity was estimated in 2 ways. Truncal adiposity was assessed using dual energy x-ray absorptiometry (DXA) prior to and at 4 wks of treatment. In addition, at the end of the experiment the animals were killed and the visceral fat was removed and weighed.

2.4. Statistical analysis 

All data were analyzed by repeated measures analysis of variance (ANOVA) using SPSS version 14.0 (SPSS Inc., Cary, NC, USA) incorporating the factors treatment, season and time. Homogeneity of variance was determined prior to analysis. Direct comparisons of means were made using single-factor ANOVA, and post-hoc analyses were performed using least significant differences. Regression analysis was used to determine the correlation between cortisol responsiveness (area under the curve) and gain in truncal adiposity.

3. Results 

return to Article Outline

3.1. Effect of ACTH treatment on plasma cortisol concentrations 

Injection of Synacthen Depot (0.5mg) increased plasma concentrations of cortisol, regardless of the season studied (JAN: P<0.05 and AUG: P<0.01). At both times of the year, cortisol concentrations were elevated for approximately 8h post-injection (Fig. 1).


View full-size image.

Fig. 1. Daily administration of Synacthen Depot, an adrenocorticotropin analogue, increases the secretion of cortisol. After injection (i.m., 0.5mg), cortisol secretion is elevated for approximately 8h, as illustrated by a representative profile (upper panels). Injection of Synacthen Depot increased the mean plasma cortisol concentration during both JAN and AUG periods (lower panels). Blood samples were taken during the control period (solid bars; black represents animals that went on to receive saline control, and white represents animals that went on to receive Synacthen Depot) and again at 4 wk of treatment (control saline-treated represented by diagonal hash bars and Synacthen Depot-treated animals represented by the horizontal hash bars). All data are presented as the mean±SEM, aaP<0.01 and aaaP<0.001 effects of Synacthen Depot treatment.


3.2. Effect of chronic elevation in cortisol concentrations on food intake, body weight, omental fat, and truncal adiposity 

Baseline food intake was greater (P<0.01) in animals in JAN (1999.8±18.9g) than in AUG (1744.5±21.9g). The effect of chronic elevation of cortisol on food intake was dependent on the time of year. During JAN, when food intake is highest, there was a transient effect of cortisol to reduce (P<0.05) food intake, but there was a return to baseline concentrations within 1 wk of treatment. During AUG, when food intake is at a nadir, elevation in cortisol caused an increase (P<0.05) in food intake for the first 3 wk of the study (Fig. 2).


View full-size image.

Fig. 2. Chronic elevation in plasma concentrations of cortisol differentially influenced food intake depending on the seasonal “set-point” of the hypothalamus. During JAN (represented by circles), increasing cortisol concentrations reduced food intake (white circles) during the first wk of the experiment, after which food intake normalized and was similar to control animals (black circles). In contrast, during AUG (represented by triangles), increasing plasma concentrations of cortisol (white triangle) increased food intake nearly for the entire duration of the experiment. In the control animals (black triangles), food intake fluctuated across the 4-wk period and was greater between d 10-15. All data are presented as the mean, and the variation is represented by the standard error of the difference (SED) for all treatments. cP<0.05 effect of time compared to pretreatment values.


In spite of the differential effect of elevated cortisol concentrations on food intake in JAN and AUG, there was no effect of increased cortisol concentrations on body weight (Fig. 3) or adiposity (as determined by omental fat weight and DXA; Fig. 3). Total truncal adiposity (% adiposity) was reduced (P<0.05) during AUG compared to JAN. Nonetheless, the degree of cortisol responsiveness, determined by analysis of the area under the curve after ACTH injection, was correlated to the propensity of individual animals to gain truncal fat, and the direction of this correlation was dependent on the season studied (Fig. 4). In JAN, cortisol responsiveness was positively correlated (P<0.05) to the propensity to gain truncal fat across the injection period, whereas in AUG this was a negative (P=0.06) correlation (Fig. 4).


View full-size image.

Fig. 3. The effects of chronic elevation in plasma cortisol concentrations on body weight and adiposity in the ovariectomized ewe. There was no effect of chronic cortisol treatment on the cumulative weight gain of animals during either JAN or AUG (upper panel), nor was there any effect of cortisol treatment on visceral adiposity (upper middle panel) or gain in truncal adiposity (lower middle panel) during JAN or AUG. The % adiposity, as determined by dual-energy x-ray absorptiometry (DXA) was lower in animals during AUG, but there was no effect of cortisol treatment in JAN or AUG. The solid bars represent data before treatment, and the hatched bars represent data after 4 wk of treatment. All data are presented as the mean±SEM.bbbP<0.001 effect of season JAN versus AUG.



View full-size image.

Fig. 4. Cortisol responsiveness to injection of adrenocorticotropin (ACTH) was differentially correlated to the change in truncal adiposity in JAN and AUG. Cortisol responsiveness was determined by calculating the area under the curve after injection of ACTH. Change in truncal adiposity was determined by the difference from control wk and wk 4 of DXA analysis. During JAN (left panel), cortisol responsiveness was positively correlated (P<0.05) to the gain in truncal adiposity, whereas in AUG (left panel) there was an inverse correlation (P=0.06) between cortisol responsiveness and the gain in truncal adiposity.


3.3. Effect of chronic elevation in cortisol concentration on plasma concentrations of leptin, insulin and glucose 

Pretreatment plasma concentrations of leptin were reduced (P<0.05) in AUG compared to JAN, and effects of cortisol treatment were dependent on the season (Fig. 5a). Plasma concentrations of leptin were reduced (P<0.05) in saline-treated animals in JAN, but this effect was not apparent in the cortisol-treated group. In AUG, however, cortisol treatment increased (P<0.05) plasma concentrations of leptin (Fig. 5a). To characterize metabolic state, we measured plasma concentrations of glucose and insulin. Pretreatment glucose concentrations were greater (P<0.05) during AUG, but insulin concentrations were similar during JAN and AUG. Elevation in plasma cortisol concentrations led to increased (P<0.05) glucose concentrations for the first 2 wk of treatment in AUG, but concentrations remained elevated after 4 wk of treatment in JAN (Fig. 5b). In JAN, plasma concentrations of insulin were increased in animals with increased cortisol concentrations for the first 3 wk of ACTH treatment (Fig. 5c). There was no effect of increased cortisol concentration on insulin concentrations in AUG (Fig. 5c).


View full-size image.

Fig. 5. Effects of chronic elevation of cortisol on plasma concentrations of leptin (panel A), glucose (panels B and C), and insulin (panels D and E). The pretreatment plasma concentrations of leptin were reduced (P<0.05) during AUG compared to JAN. Concentrations of leptin were reduced (P<0.05) in saline-treated animals in JAN only, but increased (P<0.05) with ACTH treatment during the AUG period. Plasma concentrations of glucose were greater (P<0.05) in animals during AUG. Chronic elevation in cortsiol concentrations increased concentrations of glucose, although this effect was greater in JAN compared to AUG. Plasma concentrations of insulin were similar in JAN and AUG. In JAN only, plasma concentrations of insulin were increased in animals with elevated (P<0.05) concentrations of cortisol. aP<0.05 denotes an effect of cortisol, bP<0.05 denotes an effect of season and cP<0.05 denotes an effect of time compared to pretreatment values.


3.4. Effect of chronic elevation in cortisol secretion on the secretory profiles of GH and gonadotropins 

To characterize the secretory profile of GH, we analyzed the mean GH concentration, the interpulse interval, and the GH pulse amplitude. The secretion of GH was similar in JAN and AUG (Fig. 6). There was no effect of chronic elevation in cortisol concentration on any of the GH parameters studied (Fig. 6).


View full-size image.

Fig. 6. Schematic illustration of the effects of chronic elevation in plasma concentrations of cortisol on the secretory profile of growth hormone. Blood samples were taken during the control period (solid bars; black represents animals that went on to receive saline control, and white represents animals that went on to receive cortisol) and again at 4 wk of treatment (control saline-treated represented by diagonal hash bars, and cortisol-treated animals represented by the horizontal hash bars). The mean concentration (panel A) and pulse amplitude (panel C) were reduced, whereas the interpulse interval (panel B) was increased after treatment in both the control and cortisol-treated groups. All data are presented as the mean±SEM, cP<0.05 effect of time compared to pretreatment values. Solid bars illustrate data prior to treatment, and hatched bars represent data after 4 wk of treatment.


Chronic elevation in cortisol had minimal effects on the secretion of gonadotropins. There was no effect of chronic elevation in cortisol concentrations on the mean plasma concentration of either LH or FSH in either JAN or AUG (Fig. 7). Cortisol treatment reduced the pulse frequency of LH, as indicated by an increase in the interpulse interval; an effect that occurred in both JAN and AUG (Fig. 7). Furthermore, increased cortisol concentration reduced the LH pulse amplitude in JAN only (Fig. 7).


View full-size image.

Fig. 7. Schematic illustration of the effects of chronic elevation in plasma cortisol concentrations on the secretion of gonadotropins. The secretion of LH was assessed by characterizing the mean plasma concentration (panel A), the interpulse interval (panel B) and the pulse amplitude (panel C). In addition, the mean concentration of FSH (panel D) was evaluated. Blood samples were taken during the control period (solid bars; black represents animals that went on to receive saline control, and white represents animals that went on to receive cortisol) and again at 4 wk of treatment (control saline-treated represented by diagonal). There was no effect of chronic elevation in cortisol concentrations on the mean concentration of LH (panel A) or FSH (panel D). Cortisol treatment increased the interpulse interval of LH (panel B) in both JAN and AUG, whereas the pulse amplitude of LH (panel C) was reduced in JAN only. Solid bars illustrate data prior to treatment, and the hatched bars represent data after 4 wk of treatment. All data are presented as the mean±SEM, cP<0.05 effect of time compared to pretreatment values.


4. Discussion 

return to Article Outline

The current study demonstrates that effects of cortisol treatment on food intake and adiposity were dependent on the set-point of the hypothalamus, typified by different responses in JAN and AUG. Furthermore, effects of treatment on plasma concentrations of leptin were seen in AUG (when adiposity and leptin concentrations are low), but effects of cortisol on concentrations of glucose and insulin were greater in JAN (when food intake and levels of adiposity are high). In contrast, elevated cortisol concentrations had minimal effect on the secretion of GH, LH, and FSH in either JAN or AUG. These studies demonstrate that long-term elevation of plasma cortisol concentrations in ovariectomized ewes has a greater impact on food intake and metabolic function than on pituitary hormone secretion and that effects are dependent on the metabolic set-point of the hypothalamus, which is determined by season (photoperiod).

Sheep, like other seasonal mammals, exhibit distinct photoperiodic-driven cycles in feeding behavior and adiposity [14], [24], [25]. Under conditions of natural photoperiod, we have previously demonstrated that sheep exhibit a circannual cycle in voluntary food intake (VFI). At our location with our breed of sheep, intake is maximal during summer/autumn and then declines to reach a nadir in late winter/early spring [14], [26], [27]. These natural shifts in food intake coincide with endogenous changes in the expression of appetite-regulating peptides in the hypothalamus. For example, the expression of neuropeptide Y (NPY) mRNA is highest when food intake is at the zenith and lowest when food intake is at the nadir [14]. These innate changes in the set-point of the hypothalamus appear to influence the way that increased plasma cortisol concentrations change food intake and other metabolic variables. When VFI was highest (JAN), treatment to elevate cortisol concentrations had a transient effect to inhibit food intake, but VFI was increased at the time of year (AUG) when lowered NPY expression causes reduced baseline VFI. In rodents, NPY has been shown to be integral to the glucocorticoid-associated effects on feeding, since adrenalectomy abolishes NPY-induced feeding and the subsequent manifestation of obesity [28]. Given the well-documented interaction between NPY and the glucocorticoid system in regulating food intake and metabolism, it is not surprising that seasonal differences in hypothalamic NPY activity are associated with different cortisol-induced feeding responses in sheep. Thus, at the time of the year when NPY expression is low and VFI is low, up-regulation can be achieved with increased cortisol concentrations.

In the current study, we found that chronic cortisol treatment did not affect body weight or adiposity in either experimental setting. It is possible that 4 wk of treatment was not sufficient to reveal any morphometric change. In this limited cohort of animals, however, the degree of cortisol responsiveness to ACTH injection was correlated to the propensity of individual animals to gain truncal fat. During JAN, animals that exhibited increased cortisol responsiveness displayed greater tendency to accumulate truncal adiposity. Interestingly, during AUG there was an inverse correlation between cortisol responsiveness and truncal adiposity, again highlighting the importance of the hypothalamic set-point in cortisol-induced changes in energy balance and adiposity.

In addition to changes in NPY expression, season (photoperiod) influences gene expression for melanin-concentrating hormone (MCH) and orexin in the lateral hypothalamus [13]. Expression of MCH and orexin mRNA is high when NPY expression and food intake are high, and there is little effect of season on the expression of POMC in the ARC [13], [14]. There is a clear association between levels of adiposity and the expression of orexin and MCH mRNA [13]. This positive correlation exists regardless of gene expression in the ARC and may not be associated with changes in food intake [13]. The current study clearly demonstrates effects of season on both food intake and predisposition to gain adipose tissue, yet these effects are divergent in that cortisol responsiveness was positively associated with fat gain without an effect on food intake (JAN), but was negatively associated with fat gain when food intake was increased (AUG). This dichotomy may be caused by changes in orexin and MCH that lead to altered rates of energy expenditure [30], [31], [32].

It has been hypothesized that the glucocorticoid-induced inhibition of GH secretion in humans leads to weight gain under conditions where cortisol concentrations are increased [3]. In ruminants, glucocorticoid-induced inhibition is less apparent, as acute isolation restraint stress (15min) has been shown to increase plasma GH concentrations in sheep [35], and acute but sustained increases in cortisol also increase GH release in cows [36]. In, another study of rams, infusion of cortisol (4h) did not change plasma GH concentrations but attenuated growth hormone-releasing hormone–stimulated GH secretion [37]. In the current study, we found that chronic elevation of plasma cortisol concentrations did not affect plasma GH concentrations. Although there was a reduction in the secretion of GH compared to pre-treatment, this effect occurred in both cortisol- and saline-treated animals. The current data, therefore, demonstrate a lack of association between cortisol responsiveness, GH inhibition, and the propensity to gain weight in ovariectomized ewes.

Stress- or cortisol-induced inhibition of reproduction manifests as a reduction in the sensitivity of the gonadotrope to the stimulatory effect of gonadotropin-releasing hormone (GnRH) [38], [39], [40], [41], as well as a reduction in the secretion of GnRH [42], [43]. Chronic elevation in plasma concentrations of cortisol, however, had minimal effects on the secretion of LH or FSH; there was no effect of elevated cortisol concentrations on the mean concentration of LH or FSH, although the secretory dynamics of LH were altered. Typically, acute elevation in cortisol concentrations leads to a reduction in the pulse amplitude of LH [38], [39], [40], [41], whereas chronic elevation in plasma cortisol concentrations, as demonstrated by the current study, predominantly inhibits LH secretion by reducing the frequency of LH pulses regardless of photoperiod. This mode of reduction suggests that chronically elevated cortisol concentrations may reduce LH secretion indirectly by inhibiting pulsatile GnRH release from the hypothalamus. Furthermore, chronic elevation in cortisol concentrations was shown to reduce LH pulse amplitude, but the effect was restricted to the JAN period only. Previous studies using gonadectomized ewes have demonstrated that acute elevation in cortisol concentrations decreases LH pulse amplitude, regardless of season [44], whereas stress reduces LH pulse amplitude in intact animals only during the anestrous period [41]. The current data demonstrate inhibition of LH secretion by chronic treatment regardless of season. Whereas it is most likely that the chronic treatment reduces GnRH secretion in both seasons, a possible pituitary effect on the gonadotrope, to reduce pulse amplitude, is seen only in the breeding season.

We have demonstrated that pretreatment plasma glucose concentrations were greater in AUG than in JAN, which was somewhat unexpected, since food intake and adiposity are lower in AUG. Nonetheless, elevation in cortisol concentrations led to increased plasma glucose concentrations in JAN and AUG. In sheep, dexamethasone treatment increases plasma glucose concentrations [45]. Similarly, in cows, acute infusion of cortisol increased plasma glucose concentrations [36]. The effects of chronic elevation of cortisol on plasma insulin concentrations, however, were clearly dependent on the hypothalamic set-point, which was increased by ACTH treatment in JAN only. To determine whether these differences translate to altered insulin sensitivity, glucose and insulin clamps or tolerance tests are required.

The pretreatment plasma concentrations of leptin were reduced in animals in AUG, consistent with the lower levels of adiposity during this period [9], [13]. Dexamethasone treatment increases leptin concentrations in obese and non-obese humans [48], [49], but we found that treatment with ACTH increased leptin concentrations in sheep in AUG only. During JAN, leptin concentrations were reduced in the saline-treated control animals, but not those in the cortisol-treated group. Thus, in AUG, ACTH treatment and elevated cortisol concentrations increased leptin concentrations during periods when endogenous concentrations were low. In spite of elevated concentrations of leptin, animals in AUG exhibited increased food intake, indicating the development of a leptin-resistant state. In addition, photoperiod is known to influence leptin sensitivity, and it is thought that during JAN, animals are leptin resistant [27]. Nonetheless, changes in leptin concentrations were not indicative of the effects of cortisol on food intake.

In summary, we have shown that effects of chronic elevation in plasma cortisol concentrations on food intake, adiposity, and metabolism in ovariectomized ewes are dependent on seasonal changes in metabolic set-point. Our results suggest that inherent differences in cortisol responsiveness to ACTH challenge may be a major determinant of the predisposition to obesity. We conclude that the “set-point” of the hypothalamus is an important determinant of the response to elevated cortisol concentrations.

Disclosures: The authors declare no conflict of interest.

Acknowledgments 

return to Article Outline

The authors wish to acknowledge Ms. Alexandra Rao, Ms. Kathryn Backholer, Ms. Jessica Thomas, and Ms. Sofie Saleh for technical assistance pertaining to radioimmunoassay and metabolic analyses. We also wish to thank Mr. Bruce Doughton and Ms. Linda Morrish for animal husbandry. This work was supported by the National Health and Medical Research Council of Australia. Dr. B. A. Henry is a recipient of a CJ Martin Fellowship.

References 

return to Article Outline

[1]. [1]McEwen BS. Glucocorticoids, depression, and mood disorders: Structural remodeling in the brain. Metabolism. 2005;54:20–23. Abstract | Full Text | Full-Text PDF (91 KB) | CrossRef

[2]. [2]McEwen BS. Central effects of stress hormones in health and disease: Understanding the protective and damaging effects of stress and stress mediators. Eur J Pharmacol. 2008;583:174–185. CrossRef

[3]. [3]Nass R, Thorner MO. Impact of the gh-cortisol ratio on the age-dependent changes in body composition. Growth Horm IGF Res. 2002;12:147–161. MEDLINE | CrossRef

[4]. [4]Epel E, Lapidus R, McEwen B, Brownell K. Stress may add bite to appetite in women: A laboratory study of stress-induced cortisol and eating behavior. Psychoneuroendocrinology. 2001;26:37–49. Abstract | Full Text | Full-Text PDF (104 KB) | CrossRef

[5]. [5]Adam TC, Epel ES, Stress . eating and the reward system. Physiol Behav. 2007;91:449–458. CrossRef

[6]. [6]Livingstone DE, Kenyon CJ, Walker BR. Mechanisms of dysregulation of 11 beta-hydroxysteroid dehydrogenase type 1 in obese zucker rats. J Endocrinol. 2000;167:533–539. MEDLINE | CrossRef

[7]. [7]Makimura H, Mizuno TM, Roberts J, Silverstein J, Beasley J, Mobbs CV. Adrenalectomy reverses obese phenotype and restores hypothalamic melanocortin tone in leptin-deficient ob/ob mice. Diabetes. 2000;49:1917–1923. MEDLINE | CrossRef

[8]. [8]Engler D, Pham T, Fullerton MJ, Funder JW, Clarke IJ. Studies of the regulation of the hypothalamic-pituitary-adrenal axis in sheep with hypothalamic-pituitary disconnection. I. Effect of an audiovisual stimulus and insulin-induced hypoglycemia. Neuroendocrinology. 1988;48:551–560. MEDLINE | CrossRef

[9]. [9]Lincoln GA, Rhind SM, Pompolo S, Clarke IJ. Hypothalamic control of photoperiod-induced cycles in food intake, body weight, and metabolic hormones in rams. Am J Physiol Regul Integr Comp Physiol. 2001;281:R76–R90. MEDLINE

[10]. [10]Udden J, Bjorntorp P, Arner P, Barkeling B, Meurling L, Rossner S. Effects of glucocorticoids on leptin levels and eating behaviour in women. J Intern Med. 2003;253:225–231. MEDLINE | CrossRef

[11]. [11]Jahng JW, Kim NY, Ryu V, et al. Dexamethasone reduces food intake, weight gain and the hypothalamic 5-ht concentration and increases plasma leptin in rats. Eur J Pharmacol. 2008;581:64–70. CrossRef

[12]. [12]Pecoraro N, Reyes F, Gomez F, Bhargava A, Dallman MF. Chronic stress promotes palatable feeding, which reduces signs of stress: Feedforward and feedback effects of chronic stress. Endocrinology. 2004;145:3754–3762. MEDLINE | CrossRef

[13]. [13]Anukulkitch C, Rao A, Dunshea FR, Clarke IJ. A test of the lipostat theory in a seasonal (ovine) model under natural conditions reveals close relationship between adiposity and melanin concentrating hormone expression. Domest Anim Endocrinol. 2009;36:138–151. Abstract | Full Text | Full-Text PDF (1268 KB) | CrossRef

[14]. [14]Clarke IJ, Scott CJ, Rao A, Pompolo S, Barker-Gibb ML. Seasonal changes in the expression of neuropeptide y and pro-opiomelanocortin mrna in the arcuate nucleus of the ovariectomized ewe: Relationship to the seasonal appetite and breeding cycles. J Neuroendocrinol. 2000;12:1105–1111. MEDLINE | CrossRef

[15]. [15]van Lier E, Perez-Clariget R, Forsberg M. Sex differences in cortisol secretion after administration of an acth analogue in sheep during the breeding and non-breeding season. Anim Reprod Sci. 2003;79:81–92. Abstract | Full Text | Full-Text PDF (140 KB) | CrossRef

[16]. [16]Bocking AD, McMillen IC, Harding R, Thorburn GD. Effect of reduced uterine blood flow on fetal and maternal cortisol. J Dev Physiol. 1986;8:237–245. MEDLINE

[17]. [17]Thomas GB, Cummins JT, Francis H, Sudbury AW, McCloud PI, Clarke IJ. Effect of restricted feeding on the relationship between hypophysial portal concentrations of growth hormone (gh)-releasing factor and somatostatin, and jugular concentrations of gh in ovariectomized ewes. Endocrinology. 1991;128:1151–1158. MEDLINE | CrossRef

[18]. [18]Lee VW, Cumming IA, de Kretser DM, Findlay JK, Hudson B, Keogh EJ. Regulation of gonadotrophin secretion in rams from birth to sexual maturity. I. Plasma lh, fsh and testosterone levels. J Reprod Fertil. 1976;46:1–6. MEDLINE | CrossRef

[19]. [19]Bremner WJ, Findlay JK, Lee VW, de Kretser DM, Cumming IA. Feedback effects of the testis on pituitary responsiveness to luteinizing hormone-releasing hormone infusions in the ram. Endocrinology. 1980;106:329–336. MEDLINE | CrossRef

[20]. [20]Blache D, Tellam RL, Chagas LM, Blackberry MA, Vercoe PE, Martin GB. Level of nutrition affects leptin concentrations in plasma and cerebrospinal fluid in sheep. J Endocrinol. 2000;165:625–637. MEDLINE | CrossRef

[21]. [21]Henry BA, Goding JW, Alexander WS, et al. Central administration of leptin to ovariectomized ewes inhibits food intake without affecting the secretion of hormones from the pituitary gland: Evidence for a dissociation of effects on appetite and neuroendocrine function. Endocrinology. 1999;140:1175–1182. MEDLINE | CrossRef

[22]. [22]Clarke IJ. Variable patterns of gonadotropin-releasing hormone secretion during the estrogen-induced luteinizing hormone surge in ovariectomized ewes. Endocrinology. 1993;133:1624–1632. MEDLINE | CrossRef

[23]. [23]Fletcher TP, Clarke IJ. Effects of hypothyroidism on the growth hormone axis in sheep. J Endocrinol. 1994;140:495–502. MEDLINE | CrossRef

[24]. [24]Mercer JG, Tups A. Neuropeptides and anticipatory changes in behaviour and physiology: Seasonal body weight regulation in the siberian hamster. Eur J Pharmacol. 2003;480:43–50. MEDLINE | CrossRef

[25]. [25]Clarke IJ. Models of “obesity” in large animals and birds. Front Horm Res. 2008;36:107–117.

[26]. [26]Clarke IJ. Sex and season are major determinants of voluntary food intake in sheep. Reprod Fertil Dev. 2001;13:577–582. MEDLINE | CrossRef

[27]. [27]Clarke IJ, Tilbrook AJ, Turner AI, Doughton BW, Goding JW. Sex, fat and the tilt of the earth: Effects of sex and season on the feeding response to centrally administered leptin in sheep. Endocrinology. 2001;142:2725–2728. MEDLINE | CrossRef

[28]. [28]Sainsbury A, Cusin I, Rohner-Jeanrenaud F, Jeanrenaud B. Adrenalectomy prevents the obesity syndrome produced by chronic central neuropeptide y infusion in normal rats. Diabetes. 1997;46:209–214. MEDLINE

[30]. [30]Teske JA, Billington CJ, Kotz CM. Neuropeptidergic mediators of spontaneous physical activity and non-exercise activity thermogenesis. Neuroendocrinology. 2008;87:71–90. CrossRef

[31]. [31]Ito M, Gomori A, Ishihara A, et al. Characterization of mch-mediated obesity in mice. Am J Physiol Endocrinol Metab. 2003;284:E940–E945. MEDLINE

[32]. [32]Astrand A, Bohlooly YM, Larsdotter S, et al. Mice lacking melanin-concentrating hormone receptor 1 demonstrate increased heart rate associated with altered autonomic activity. Am J Physiol Regul Integr Comp Physiol. 2004;287:R749–R758. MEDLINE | CrossRef

[35]. [35]Cataldi M, Magnan E, Guillaume V, et al. Acute stress stimulates secretion of ghrh and somatostatin into hypophysial portal blood of conscious sheep. Neurosci Lett. 1994;178:103–106. MEDLINE | CrossRef

[36]. [36]Ting ST, Earley B, Crowe MA. Effect of cortisol infusion patterns and castration on metabolic and immunological indices of stress response in cattle. Domest Anim Endocrinol. 2004;26:329–349. Abstract | Full Text | Full-Text PDF (272 KB) | CrossRef

[37]. [37]Thompson K, Coleman ES, Hudmon A, Kemppainen RJ, Soyoola EO, Sartin JL. Effects of short-term cortisol infusion on growth hormone-releasing hormone stimulation of growth hormone release in sheep. Am J Vet Res. 1995;56:1228–1231. MEDLINE

[38]. [38]Breen KM, Karsch FJ. Does cortisol inhibit pulsatile luteinizing hormone secretion at the hypothalamic or pituitary level?. Endocrinology. 2004;145:692–698. MEDLINE | CrossRef

[39]. [39]Breen KM, Stackpole CA, Clarke IJ, et al. Does the type ii glucocorticoid receptor mediate cortisol-induced suppression in pituitary responsiveness to gonadotropin-releasing hormone?. Endocrinology. 2004;145:2739–2746. MEDLINE | CrossRef

[40]. [40]Pierce BN, Hemsworth PH, Rivalland ET, et al. Psychosocial stress suppresses attractivity, proceptivity and pulsatile lh secretion in the ewe. Horm Behav. 2008;54:424–434. CrossRef

[41]. [41]Stackpole CA, Turner AI, Clarke IJ, Lambert GW, Tilbrook AJ. Seasonal differences in the effect of isolation and restraint stress on the luteinizing hormone response to gonadotropin-releasing hormone in hypothalamopituitary disconnected, gonadectomized rams and ewes. Biol Reprod. 2003;69:1158–1164. MEDLINE | CrossRef

[42]. [42]Oakley AE, Breen KM, Clarke IJ, Karsch FJ, Wagenmaker ER, Tilbrook AJ. Cortisol reduces gonadotropin-releasing hormone pulse frequency in follicular phase ewes: Influence of ovarian steroids. Endocrinology. 2009;150:341–349. CrossRef

[43]. [43]Oakley AE, Breen KM, Tilbrook AJ, Wagenmaker ER, Karsch FJ. Role of estradiol in cortisol-induced reduction of luteinizing hormone pulse frequency. Endocrinology. 2009;150:2775–2782. CrossRef

[44]. [44]Breen KM, Karsch FJ. Does season alter responsiveness of the reproductive neuroendocrine axis to the suppressive actions of cortisol in ovariectomized ewes?. Biol Reprod. 2006;74:41–45. MEDLINE | CrossRef

[45]. [45]Franko KL, Giussani DA, Forhead AJ, Fowden AL. Effects of dexamethasone on the glucogenic capacity of fetal, pregnant, and non-pregnant adult sheep. J Endocrinol. 2007;192:67–73. MEDLINE | CrossRef

[48]. [48]Kiess W, Englaro P, Hanitsch S, Rascher W, Attanasio A, Blum WF. High leptin concentrations in serum of very obese children are further stimulated by dexamethasone. Horm Metab Res. 1996;28:708–710. MEDLINE | CrossRef

[49]. [49]Miell JP, Englaro P, Blum WF. Dexamethasone induces an acute and sustained rise in circulating leptin levels in normal human subjects. Horm Metab Res. 1996;28:704–707. MEDLINE | CrossRef

a Department of Physiology, Building 13 F, Wellington Road, Monash University, VIC 3800, Australia

b School of Animal Biology, University of Western Australia, Crawley, WA 6009, Australia

c Melbourne School of Land and Environment, The University of Melbourne, Parkville, VIC 3010, Melbourne, Australia

Corresponding Author InformationCorresponding author. Tel.: +61 3 99052500; fax: +61 3 99052566.

PII: S0739-7240(09)00077-0

doi:10.1016/j.domaniend.2009.07.006


View previous. 7 of 8 View next.